Chief Executive Officer and President; Former Chief Operating Officer · Jasper Therapeutics, Inc. (JSPR)

Jeet Mahal

A named executive officer of Jasper Therapeutics in every fiscal year CompBrief holds from FY2023 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$1,289,599

Salary $498,000Stock awards $0

FY2024: $1,278,131

3rd of 4 named executive officers at Jasper Therapeutics by FY2025 total.

4 named officers on file for Jasper Therapeutics, FY2025

Jeet Mahal’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Jasper Therapeutics’s whole pay program stands against its peers

  • Jasper Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on JSPR→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed June 15, 2026 (DEF 14A).

Free

Get Jeet Mahal’s full pay file as a PDF — free

More than this page: up to 10 years of Jeet’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Jeet Mahal compensation by year

Jasper Therapeutics Summary Compensation Table · all 3 fiscal years held
In US dollars, as Jasper Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023FY2024FY2025
Salary$461,693$481,301$498,000
Bonus$0$0$0
Stock awards$0$0$0
Option awards$535,990$612,732$679,549
Non-equity incentive$187,024$184,098$112,050
Pension and deferred compensation$0$0$0
All other$0$0$0
Total$1,184,707$1,278,131$1,289,599

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Jasper Therapeutics, Inc. DEF 14A filed June 15, 2026, accession 0001213900-26-068765, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Jasper Therapeutics, Inc. filed document, accession 0001213900-26-068765. Every figure is read from that document and cited to the page and table it appears in. Filed June 15, 2026.

$1.2M
$1.3M
$1.3M
FY23
FY24
FY25
SalaryNon-equity incentiveOption awards

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
Option546—$35.40
Option303—$31.20
Option10,942—$18.70
Option21,667—$17.95
Option50,000—$6.20
Option90,000—$6.00

Per the Outstanding Equity Awards at Fiscal Year-End table in Jasper Therapeutics, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Jasper Therapeutics’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Ronald MartellFormer Chief Executive Officer and President$2,494,099
Edwin TuckerFormer Chief Medical Officer$1,537,032
Jeet Mahal · this pageChief Executive Officer and President; Former Chief Operating Officer$1,289,599
Herb CrossChief Financial Officer and Corporate Secretary$1,283,474

The full Jasper Therapeutics compensation record

free company brief

This page is one person within Jasper Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Jasper Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Jeet Mahal's compensation dossier · One-time report. No refunds.